A Case Study: New Flu Vaccine

The flu is an illness that normally occurs in fall or winter season. Our approach to this project is to purchase all of our supplies and equipment in a timely manner. In order to meet our deliverables, we have chosen a few vendors throughout Colorado that have a great reputation of providing excellent service to many of their customer. The most important vendor to the Flu Shot Administration project is the purchasing of medical supplies and equipment. We plan to purchase majority of our medical supplies from McKesson Corporation. We thought it would be best to contract with McKesson Corporation because they are located in Colorado. Their close proximity helps to lower transportation risks. They are well known throughout the health care industry

DALLAS (Sept. 1, 2017) – Dallas County Health and Human Services (DCHHS) is now offering the seasonal flu vaccine for adults at the main clinic on Stemmons Freeway. The cost is $20. If the adult is covered by Medicare, the vaccine is free. DCHHS is awaiting shipment of the children’s vaccine.

Yes, during the vaccine crisis in 2003-2004, CDC acted promptly and recommended all healthcare facilities to immunize the high-risk group patients first. After that, CDC advised the entire public health department to work with their providers to develop a pandemic influenza plans. The key elements included in the plans are influenza surveillance, vaccination, antiviral drug use, communications, healthcare system response and it also addressed who should be in the priority group for receiving the vaccine.

Influenza is common and affects people of all ages and there is a major difference in how sick you get when you suffer from flu. Many elderly people and people with impaired immune systems are often very sick. To avoid more vulnerable people affected by the flu, it is recommended that the elderly, the chronically ill and pregnant people vaccinated against influenza in October / November.

Influenza is one of the major causes for illness around the globe and vaccination is the best way for controlling it The best way for reducing the impact of influenza infection and resulting morbidity and mortality in the human population lies in immunization against influenza (Palese & Garcia.,2002) ] . Two types of vaccines are currently licensed for prevention of yearly epidemic influenza: trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV) .There are The annual vaccination (either with the intramuscular inactivated Influenza vaccine (IIV)or the intranasal live attenuated vaccine (LAIV)) continues to be the keystone of prophylactic treatment for infection associated with Influenza in humans (Pica N.

Hello, I have spoken with the president and general manager of all the locations around the country. We have decided to give additional benefits and to help inoculate employees against an illness that affects their attendance, your organization is providing flu shots to all employees at your central, and distant locations.

Vaccines that prime an immune system for a particular virus are not the only way to combat viral diseases. Antiviral drugs can be used to interfere with the life cycle of viruses limiting the rate of their infection and aiding the immune system in combating the disease. In the case of influenza, the two currently approved classes of drugs are Adamantanes and neuraminidase inhibitors. Within the Adamantanes there are two drugs Amantadine and Rimantadine where the drugs through their inhibiting effects prevent the virus from uncoating. However, recent reports have shown the CDC (2015, February 25) that currently circulating strains of influenza in the population has developed a resistance to Adamantanes due to genetic variation and natural selection

I agree that flu vaccines may not be effective most years as the type of viruses in the vaccines may not match the ones circulating. I also don’t get a flu vaccine yearly and don’t plan to unless it is required. I have only had the flu twice in almost fifty years and one of those times was a year the vaccine did not match the virus circulating and a lot of people who had the vaccine also had the flu that year. I have only been in healthcare field for seven years and have not had the flu during that time despite caring for others that had confirmed cases of the flu. The vaccine information states the vaccine will help with the severity of the flu if you were to contract the flu, but I don’t know how much less severe their case was as compared

About 5.4 million American people have Alzheimer’s, 3.5 million have autism and flu claims 36000 people annually. These statistics emphasize the importance of the treatment of such disorders. Thus, I would increase funding for projects like Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative and Universal Flu Vaccine. The BRAIN project is decoding the role of neurons in the thoughts, memories and the perception of sensory experience. More funding can result in treatment of mental disorders, like Alzheimer’s, ADHD, autism, schizophrenia, and depression, affecting both young and old. Moreover, because of the continuous evolution of flu virus, annual administration of modified flu shots costs $87 billion. The Universal

The role of hemagglutinin (HA) , which is one of the abundant & immunodominant glycoprotein on the surface of the influenza virus ,is very important as an immunogen in anti-influenza vaccines (Gamblin & Skehel.,2010). HA is a major glycoprotein in the viral lipid envelope membrane with a distal globular head that mediates host-cell receptor binding followed by a membrane-proximal stalk domain which directs fusion of viral envelope with the host cell(Kaminski &Lee ,2011). The current split-virus vaccines predominantly induce antibodies to the surface glycoprotein like HA ,NA . Due to antigenic drift ,the surface glycoproteins undergo mutations, therefore the three influenza strains are included in seasonal IIV (influenza A(H1N1) and A(H3N2) and influenza B) which are evaluated for their ability to generate neutralizing antibodies against the circulating influenza strains (Waffarn E. & Baumgarth N.,2011). . After vaccination with inactivated Influenza vaccine , it results in both local and systemic responses generation. .Within 2 weeks of vaccination, 90% of vaccines found to have protective antibody titres (Cox RJ.1994) .In humans, hemagglutinin specific effector T-cells are found to be major proliferating subsets of T-cells which are seen after stimulation by HA molecule (Novak et al 1999).

Another claim against immunization is personal opposition to big pharmaceutical companies. Some believe vaccines are charged to patients solely for profit. This pharmaceutical profit-motive can call into question product safety and integrity. The overwhelming majority of vaccines are not highly profitable though (Lam). Due to the massive investment of time and funds required to create vaccines, coupled with only marginal returns on this investment, pharmaceutical corporations do not focus on them. As result, nonprofit health organizations and political agencies such as the CDC, and the WHO, generally lead the charge in vaccine development. It is a real danger that companies will stop developing vaccines altogether (Lam). Drug companies instead concentrate on well, drugs. Continuous treatment medications require patients to purchase repeatedly, until it is no longer necessary. (In some cases, patients may even take certain drugs until death.) The time interval of vaccinations is, at the very least, yearly. In the case of the flu, rather than one flu shot, pharmaceutical companies can profit more from selling antivirals, painkillers, and a host of other treatments to patients that contract viral sickness. Medications, rather than cures are economically desirable. As a biochemistry student myself, upon graduating I face the decision between conducting decent paying scientific research or developing pharmaceuticals with the opportunity of making upwards of $200,000 a year for

It would be beneficial because of her symptoms to know if and when she received the flu shot. At her age the body’s immune response from vaccination declines over time, so an annual vaccine is needed for optimal protection. Second, because flu viruses are constantly changing, the formulation of the flu vaccine is reviewed each year and sometimes updated to keep up with changing flu

Because firm value will rise to $6,850.8 million immediately after the recapitalization announcement, original shareholders will capture the full benefit of interest tax shield since they are able to sell their stocks at a higher price. The new stock price is determined by dividing the value of the levered firm by the number of shares outstanding at the end of 1998. Since there were 185, 516,055 shares outstanding at year end 1998, the new stock price after the announcement of recapitalization would be $6,850.8 million divided by 185, 516,055, which is $36.93. Compared to the

MAIN PROBLEM TO BE RESOLVED: What would be the appropriate offering price for the new IPO shares of JetBlue Airways Corporation listed in NASDAQ which would not only help the firm raise short-term capital requirements but would also provide positive returns to its shareholders in the future?

Vaccine development is an old and complicated process, often requires more than a decade to complete. The modern system of vaccine development, regulation and testing was developed during the 20th century. To engender a vaccine mediated immunization or protection has been a major challenge. Presently available vaccines work primarily through the induction of the antigen specific antibodies. The effectiveness of any vaccine is determined by the quality of the antibodies, as their work pattern and avidity. For a long term effect through vaccines, the antibodies should be persistent or generated immune memory cells should be capable of instantaneous response in case of any microbial exposure.